Optimizing the Use of Postapproval Pregnancy Safety Studies (In-Person Registration)

A two-day Public Workshop that will gather stakeholder input on how to optimize the design and type of postapproval pregnancy safety studies of drugs and biologics regulated by the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). To attend this event virtually visit: https://duke.is/vpdva